The molecular mechanisms of the effect of Dexamethasone and Cyclosporin A on TLR4 /NF-κB signaling pathway activation in oral lichen planus

Gene

Volumn 508, Issue 2, 2012, Pages 157-164

  Ge, Yana ^a   Xu, Ye ^a   Sun, Wenjing ^b   Man, Zhaozhao ^a   Zhu, Lanlan ^a   Xia, Xianyin ^a   Zhao, Linbo ^a   Zhao, Yuzhen ^b   Wang, Xiumei ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cyclosporine A; Dexamethasone; OLP; TLR4 NF B signaling pathway

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; RNA; STEROID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC DISEASE; CYTOKINE PRODUCTION; DRUG EFFECT; EPIDERMIS CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY DISEASE; KERATINOCYTE; LICHEN PLANUS; MOUTH LICHEN PLANUS; MOUTH MUCOSA; PAIN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLOSPORINE; DEXAMETHASONE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1BETA; KERATINOCYTES; LICHEN PLANUS, ORAL; LIPOPOLYSACCHARIDES; MOUTH MUCOSA; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865764725     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.045     Document Type: Article

References (32)

1. Al-Hashimi I., et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007, (103 Suppl.):S25 e1-12.
2. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336:1066-1071.
3. Chainani-Wu N., Silverman S., Lozada-Nur F., Mayer P., Watson J.J. Oral lichen planus: patient profile, disease progression and treatment responses. J. Am. Dent. Assoc. 2001, 132:901-909.
4. Conboy I.M., Manoli D., Mhaiskar V., Jones P.P. Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6324-6329.
5. Dekker N.P., Lozada-Nur F., Lagenaur L.A., MacPhail L.A., Bloom C.Y., Regezi J.A. Apoptosis-associated markers in oral lichen planus. J. Oral Pathol. Med. 1997, 26:170-175.
6. Donjerkovic D., Mueller C.M., Scott D.W. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1). Eur. J. Immunol. 2000, 30:1154-1161.
7. Eisen D., Ellis C.N., Duell E.A., Griffiths C.E., Voorhees J.J. Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N. Engl. J. Med. 1990, 323:290-294.
8. Epstein J.B., Truelove E.L. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1996, 82:532-536.
9. Goldfeld A.E., et al. Calcineurin mediates human tumor necrosis factor alpha gene induction in stimulated T and B cells. J. Exp. Med. 1994, 180:763-768.
10. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell. Signal. 2001, 13:85-94.
11. Harpenau L.A., Plemons J.M., Rees T.D. Effectiveness of a low dose of cyclosporine in the management of patients with oral erosive lichen planus. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1995, 80:161-167.
12. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
13. Kang Y.J., et al. Calcineurin negatively regulates TLR-mediated activation pathways. J. Immunol. 2007, 179:4598-4607.
14. Karatsaidis A., Hayashi K., Schreurs O., Helgeland K., Schenck K. Survival signalling in keratinocytes of erythematous oral lichen planus. J. Oral Pathol. Med. 2007, 36:215-222.
15. Kawai T., Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 2007, 13:460-469.
16. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
17. Lopez Lopez J., Rosello Llabres X. Cyclosporine A, an alternative to the oral lichen planus erosive treatment. Bull. Group Int. Rech. Sci. Stomatol. Odontol. 1995, 38:33-38.
18. Lozada-Nur F., Miranda C. Oral lichen planus: topical and systemic therapy. Semin. Cutan. Med. Surg. 1997, 16:295-300.
19. Mattila R., Syrjanen S. Caspase cascade pathways in apoptosis of oral lichen planus. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2010, 110:618-623.
20. Moharamzadeh K., Van Noort R., Brook I.M., Scutt A.M. Cytotoxicity of resin monomers on human gingival fibroblasts and HaCaT keratinocytes. Dent. Mater. 2007, 23:40-44.
21. Mollaoglu N. Oral lichen planus: a review. Br. J. Oral Maxillofac. Surg. 2000, 38:370-377.
22. Moynagh P.N. The NF-kappaB pathway. J. Cell Sci. 2005, 118:4589-4592.
23. Neppelberg E., Johannessen A.C., Jonsson R. Apoptosis in oral lichen planus. Eur. J. Oral Sci. 2001, 109:361-364.
24. Rhodus N.L., Cheng B., Bowles W., Myers S., Miller L., Ondrey F. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Dis. 2006, 12:112-116.
25. Santoro A., Majorana A., Bardellini E., Festa S., Sapelli P., Facchetti F. NF-kappaB expression in oral and cutaneous lichen planus. J. Pathol. 2003, 201:466-472.
26. Setterfield J.F., Black M.M., Challacombe S.J. The management of oral lichen planus. Clin. Exp. Dermatol. 2000, 25:176-182.
27. Subramanyam D., Krishna S. c-Myc substitutes for Notch1-CBF1 functions in cooperative transformation with papillomavirus oncogenes. Virology 2006, 347:191-198.
28. Sugerman P.B., et al. The pathogenesis of oral lichen planus. Crit. Rev. Oral Biol. Med. 2002, 13:350-365.
29. Zhang Y., et al. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine 2008, 41:144-149.
30. Zhou H., Lin A., Gu Z., Chen S., Park N.H., Chiu R. 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced c-Jun N-terminal kinase (JNK) phosphatase renders immortalized or transformed epithelial cells refractory to TPA-inducible JNK activity. J. Biol. Chem. 2000, 275:22868-22875.
31. Zhou G., et al. Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. J. Oral Pathol. Med. 2009, 38:559-564.
32. Zunt S.L., Burton L.V., Goldblatt L.I., Dobbins E.E., Srinivasan M. Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells. Clin. Exp. Immunol. 2009, 156:285-293.